Jiangsu Hengrui Medicine Logo

Jiangsu Hengrui Medicine

🇨🇳
600276
CNE0000014W7

Jiangsu Hengrui Medicine is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and distribution of innovative medicines. The company focuses on oncology, autoimmune diseases, pain management, and metabolic disorders to improve global patient care. It drives biopharmaceutical innovation forward.

Next Quarterly Earnings

Thursday, August 20, 2026
CW 34
Pre-Market
In 45 days

Stock Price

All Dates

Company Information

Name
Jiangsu Hengrui Medicine
Ticker Symbol
600276
ISIN
CNE0000014W7
Country
🇨🇳
People's Republic of China